Last $9.03 USD
Change Today +0.06 / 0.67%
Volume 8.1K
As of 8:10 PM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

iridex corp (IRIX) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/3/14 - $10.35
52 Week Low
10/22/14 - $6.41
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for IRIDEX CORP (IRIX)

Related News

No related news articles were found.

iridex corp (IRIX) Related Businessweek News

No Related Businessweek News Found

iridex corp (IRIX) Details

IRIDEX Corporation develops, manufactures, markets, sells, and services medical laser systems and associated instrumentation for the treatment of the sight-threatening eye diseases worldwide. Its ophthalmology products consist of laser consoles, such as visible (yellow) photocoagulator console, infrared photocoagulator consoles, micropulse enabled consoles, and multi-wavelength laser system configurations. The company also provides ophthalmic delivery devices and other products, such as TxCell scanning laser delivery systems; TruFocus laser indirect ophthalmoscopes; slit lamp adapters; and operating microscope adapters. In addition, it offers EndoProbe, a fiber optic delivery device used for endophotocoagulation, a retinal treatment procedure; G-Probe, a sterile consumable multi-use product used in procedures to treat medically and surgically uncontrolled glaucoma; and DioPexy Probe, a hand-held instrument used in procedures to treat retinal tears. Further, the company provides GreenTip Soft Tip Cannula, a sterile disposable product, which allows surgeons to visualize and access the proximity of the retina while performing a fluid air exchange during a vitrectomy procedure; and MoistAir in-line air humidifier that provides humidified air to the eye during fluid air exchange. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, and office clinics. It sells and markets its products through a direct sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was founded in 1989 and is headquartered in Mountain View, California.

101 Employees
Last Reported Date: 03/27/14
Founded in 1989

iridex corp (IRIX) Top Compensated Officers

Chairman of the Board, Chief Executive Office...
Total Annual Compensation: $200.0K
Chief Financial Officer, Chief Operating Offi...
Total Annual Compensation: $284.7K
Compensation as of Fiscal Year 2013.

iridex corp (IRIX) Key Developments

IRIDEX Corporation Announces Preliminary Unaudited Revenues for the Fourth Quarter and Full Year 2014; Provides Revenue Outlook for Fiscal Year 2015

IRIDEX Corporation announced preliminary unaudited revenues for the fourth quarter and full year 2014. For the quarter, the company’s revenue was $11.5 to $11.7 million. For the year, the company’s revenue was $42.5 to $42.7 million. For the fiscal 2015, the company currently expects to generate revenues of between $48 million and $51 million.

IRIDEX Corporation Announces Board Changes

IRIDEX Corporation announced that it has appointed ophthalmology and medical laser executive George R. Marcellino, Ph.D., to its Board of Directors, effective immediately. Dr. Marcellino is a co-founder of Sunnyvale, CA-based OptiMedica Corporation, and he fills the seat vacated by James B. Hawkins, who is rotating off the Board after 7 years of service to the IRIDEX shareholders. He currently serves as vice president of clinical sciences and global advocacy. Prior to OptiMedica, from 1988 to 2003, Dr. Marcellino held senior research, sales and marketing roles at Santa Clara, CA-based Coherent, Inc, and its subsequent embodiment Lumenis Ltd. His prior medical and laser experience includes management and director level roles at Laserscope Inc., Cooper Laseronics Inc. and Oximetrix all located in the San Francisco Bay area.

IRIDEX Secures Large Ophthalmology Laser Equipment Tender to Supply Rural Chinese Regions

IRIDEX Corporation announced that its China distributor has been awarded a competitive tender for more than $620,000 in ophthalmology laser equipment to fulfill a government program designed to provide advanced ophthalmology solutions to patients across vast areas of China's rural regions. Moore added that the advances in laser-based therapies are also ushering in a paradigm shift in the U.S. and European ophthalmology markets, including diabetic macular edema (DME) and glaucoma treatments.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
IRIX:US $9.03 USD +0.06

IRIX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cutera Inc $13.44 USD -0.06
Ellex Medical Lasers Ltd A$0.35 AUD +0.04
Lutronic Corp 26,800 KRW +2,000
STAAR Surgical Co $5.71 USD -0.07
Synergetics USA Inc $4.78 USD 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation IRIX Industry Range
Price/Earnings 55.4x
Price/Sales 2.1x
Price/Book 3.4x
Price/Cash Flow 52.4x
TEV/Sales 1.8x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IRIDEX CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at